Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Behav Brain Res ; 339: 47-56, 2018 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-29109055

RESUMEN

Parkinson disease (PD) is devastating to sensorimotor function that includes cranial/oromotor and limb motor deficits. However, the onset, progression, and neural correlates of PD-related dysfunctions are poorly understood. To address this gap, we used a genetic rat model of PD, DJ1 -/-, and hypothesized that motor deficits would manifest early in the disease process, be progressive in nature, and be related to pathologies in brainstem structures associated with sensorimotor function. The present study compares homozygous DJ1 -/- male rats to age-matched wild type controls. Progressive cranial sensorimotor function (ultrasonic vocalizations and tongue motor performance) and limb motor function (tapered balance beam) was analyzed at 2, 4, 6, and 8 months of age. Additionally, tyrosine hydroxylase cell counts were performed in the locus coeruleus and correlated to behavioral measures. We found that compared to wild type controls, DJ1 -/- show deficits in ultrasonic vocalizations as well as oromotor (tongue) deficits that were progressive. Overtime, DJ1 -/- rats cross a tapered balance beam with significantly decreased speed of traversal. Additionally, in the DJ1 -/-, tyrosine hydroxylase positive cells in the locus coeruleus are significantly reduced and are negatively correlated to oromotor behaviors. Characterizing the DJ1 -/- model of PD provides important foundational work necessary to define behavioral and early-onset biomarkers that parallels early-stage PD pathology in humans.


Asunto(s)
Extremidades/fisiopatología , Enfermedad de Parkinson/fisiopatología , Proteína Desglicasa DJ-1/metabolismo , Lengua/fisiopatología , Vocalización Animal/fisiología , Animales , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Masculino , Proteína Desglicasa DJ-1/genética , Ratas Long-Evans , Tirosina 3-Monooxigenasa/metabolismo
2.
Soc Neurosci ; 11(4): 365-79, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26313334

RESUMEN

Many individuals with Parkinson disease (PD) have difficulty producing normal speech and voice, resulting in problems with interpersonal communication and reduced quality of life. Translational animal models of communicative dysfunction have been developed to assess disease pathology. However, it is unknown whether acoustic feature changes associated with vocal production deficits in these animal models lead to compromised communication. In rodents, male ultrasonic vocalizations (USVs) have a well-established role in functional inter-sexual communication. To test whether acoustic deficits in USVs observed in a PTEN-induced putative kinase 1 (PINK1) knockout (KO) PD rat model compromise communication, we presented recordings of male PINK1 KO USVs and normal wild-type (WT) USVs to female rat listeners. We measured approached behavior and immediate early gene expression (c-Fos) in brain regions implicated in auditory processing and sexual motivation. Our results suggest that females show reduced approach in response to PINK1 KO USVs compared with WT. Moreover, females exposed to PINK1 KO USVs had lower c-Fos immunolabeling in the nucleus accumbens, a region implicated in sexual motivation. These results are the first to demonstrate that vocalization deficits in a rat PD model result in compromised communication. Thus, the PINK1 KO PD model may be valuable for assessing treatments aimed at restoring vocal communicative function.


Asunto(s)
Percepción Auditiva/genética , Núcleo Accumbens/metabolismo , Enfermedad de Parkinson/fisiopatología , Proteínas Proto-Oncogénicas c-fos/metabolismo , Conducta Social , Vocalización Animal/fisiología , Estimulación Acústica , Animales , Modelos Animales de Enfermedad , Femenino , Masculino , Enfermedad de Parkinson/genética , Juego e Implementos de Juego/psicología , Proteínas Quinasas/deficiencia , Proteínas Quinasas/genética , Proteínas Proto-Oncogénicas c-fos/genética , Ratas , Ratas Long-Evans , Ratas Transgénicas , Espectrografía del Sonido , Estadísticas no Paramétricas , Ultrasonido
3.
J Neurosci Res ; 93(11): 1713-27, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26234713

RESUMEN

Parkinson's disease (PD) is a progressive neurodegenerative disease that leads to a wide range of motor and nonmotor deficits. Specifically, voice and swallow deficits manifest early, are devastating to quality of life, and are difficult to treat with standard medical therapies. The pathological hallmarks of PD include accumulation of the presynaptic protein α-synuclein (αSyn) as well as degeneration of substantia nigra dopaminergic neurons. However, there is no clear understanding of how or when this pathology contributes to voice and swallow dysfunction in PD. The present study evaluates the effect of loss of function of the phosphatase and tensin homolog-induced putative kinase 1 gene in rats (PINK1(-/-) ), a model of autosomal recessive PD in humans, on vocalization, oromotor and limb function, and neurodegenerative pathologies. Behavioral measures include ultrasonic vocalizations, tongue force, biting, and gross motor performance that are assayed at 2, 4, 6, and 8 months of age. Aggregated αSyn and tyrosine hydroxylase immunoreactivity (TH-ir) were measured at 8 months. We show that, compared with wild-type controls, PINK1(-/-) rats develop (1) early and progressive vocalization and oromotor deficits, (2) reduced TH-ir in the locus coeruleus that correlates with vocal loudness and tongue force, and (3) αSyn neuropathology in brain regions important for cranial sensorimotor control. This novel approach of characterizing a PINK1(-/-) genetic model of PD provides the foundational work required to define behavioral biomarkers for the development of disease-modifying therapeutics for PD patients.


Asunto(s)
Ataxia/genética , Encéfalo/patología , Enfermedad de Parkinson/genética , Proteínas Quinasas/genética , Vocalización Animal/fisiología , Animales , Modelos Animales de Enfermedad , Técnicas de Inactivación de Genes , Inmunohistoquímica , Masculino , Actividad Motora/genética , Fuerza Muscular/genética , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/patología , Ratas , Ratas Long-Evans , Lengua/inervación , Tirosina 3-Monooxigenasa/genética , Tirosina 3-Monooxigenasa/metabolismo , alfa-Sinucleína/genética , alfa-Sinucleína/metabolismo
4.
Semin Speech Lang ; 34(3): 185-202, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24166192

RESUMEN

Parkinson disease (PD) is a complex, progressive, neurodegenerative disorder that leads to a wide range of deficits including fine and gross sensorimotor impairment, autonomic dysfunction, mood disorders, and cognitive decline. Traditionally, the focus for diagnosis and treatment has been on sensorimotor impairment related to dopamine depletion. It is now widely recognized, however, that PD-related pathology affects multiple central nervous system neurotransmitters and pathways. Communication and swallowing functions can be impaired even in the early stages, significantly affecting health and quality of life. The purpose of this article is to review the literature on early intervention for communication and swallowing impairment in PD. Overarching themes were that (1) studies and interpretation of data from studies in early PD are limited; (2) best therapy practices have not been established, in part due to the heterogeneous nature of PD; and (3) as communication and swallowing problems are pervasive in PD, further treatment research is essential.


Asunto(s)
Trastornos de la Comunicación , Trastornos de Deglución , Disartria , Enfermedad de Parkinson , Patología del Habla y Lenguaje , Trastornos de la Comunicación/diagnóstico , Trastornos de la Comunicación/etiología , Trastornos de la Comunicación/terapia , Trastornos de Deglución/diagnóstico , Trastornos de Deglución/etiología , Trastornos de Deglución/terapia , Disartria/diagnóstico , Disartria/etiología , Disartria/terapia , Diagnóstico Precoz , Humanos , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/diagnóstico , Enfermedad de Parkinson/terapia , Guías de Práctica Clínica como Asunto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA